| Value |
Description |
German Interpretation |
Comment |
Chapter |
| AB |
Abbott Laboratories |
|
(includes Ross Products Division) |
2.C.2.83 |
| AD |
Adams Laboratories, Inc. |
|
|
2.C.2.83 |
| ALP |
Alpha Therapeutic Corporation |
|
|
2.C.2.83 |
| AR |
Armour |
|
[Inactive--use AVB] |
2.C.2.83 |
| AVB |
Aventis Behring L.L.C. |
|
(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB] CDC Changes made on: Feb. 28, 2006 |
2.C.2.83 |
| AVI |
Aviron |
|
|
2.C.2.83 |
| BA |
Baxter Healthcare Corporation |
|
[Inactive--use BAH] |
2.C.2.83 |
| BAH |
Baxter Healthcare Corporation |
|
(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.) |
2.C.2.83 |
| BAY |
Bayer Corporation |
|
(includes Miles, Inc. and Cutter Laboratories) |
2.C.2.83 |
| BP |
Berna Products |
|
[Inactive--use BPC] |
2.C.2.83 |
| BPC |
Berna Products Corporation |
|
(includes Swiss Serum and Vaccine Institute Berne) |
2.C.2.83 |
| MIP |
Bioport Corporation |
|
(formerly Michigan Biologic Products Institute) |
2.C.2.83 |
| CNJ |
Cangene Corporation |
|
CDC Changes made on: Feb. 28, 2006 |
2.C.2.83 |
| CMP |
Celltech Medeva Pharmaceuticals |
|
[Inactive--use NOV] CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| CEN |
Centeon L.L.C. |
|
[Inactive--use AVB] |
2.C.2.83 |
| CHI |
Chiron Corporation |
|
[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Medical Limited CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| CON |
Connaught |
|
[Inactive--use PMC] |
2.C.2.83 |
| DVC |
DynPort Vaccine Company, LLC |
|
CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| EVN |
Evans Medical Limited |
|
[Inactive--use NOV] CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| GEO |
GeoVax Labs, Inc. |
|
CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| SKB |
GlaxoSmithKline |
|
(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome) |
2.C.2.83 |
| GRE |
Greer Laboratories, Inc. |
|
|
2.C.2.83 |
| IAG |
Immuno International AG |
|
[Inactive--use BAH] |
2.C.2.83 |
| IUS |
Immuno-U.S., Inc. |
|
|
2.C.2.83 |
| KGC |
Korea Green Cross Corporation |
|
|
2.C.2.83 |
| LED |
Lederle |
|
[Inactive--use WAL] |
2.C.2.83 |
| MBL |
Massachusetts Biologic Laboratories |
|
(formerly Massachusetts Public Health Biologic Laboratories) |
2.C.2.83 |
| MA |
Massachusetts Public Health Biologic Laboratories |
|
[Inactive--use MBL] |
2.C.2.83 |
| MED |
MedImmune, Inc. |
|
|
2.C.2.83 |
| MSD |
Merck & Co., Inc. |
|
|
2.C.2.83 |
| IM |
Merieux |
|
[Inactive--use PMC] |
2.C.2.83 |
| MIL |
Miles |
|
[Inactive--use BAY] |
2.C.2.83 |
| NAB |
NABI |
|
(formerly North American Biologicals, Inc.) |
2.C.2.83 |
| NYB |
New York Blood Center |
|
|
2.C.2.83 |
| NAV |
North American Vaccine, Inc. |
|
[Inactive--use BAH] |
2.C.2.83 |
| NOV |
Novartis Pharmaceutical Corporation |
|
(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited) |
2.C.2.83 |
| NVX |
Novavax, Inc. |
|
CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| OTC |
Organon Teknika Corporation |
|
|
2.C.2.83 |
| ORT |
Ortho-Clinical Diagnostics |
|
(formerly Ortho Diagnostic Systems, Inc.) |
2.C.2.83 |
| PD |
Parkedale Pharmaceuticals |
|
(formerly Parke-Davis) |
2.C.2.83 |
| PWJ |
PowderJect Pharmaceuticals |
|
(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| PRX |
Praxis Biologics |
|
[Inactive--use WAL] |
2.C.2.83 |
| PMC |
sanofi pasteur |
|
(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006 |
2.C.2.83 |
| JPN |
The Research Foundation for Microbial Diseases of Osaka University |
|
(BIKEN) |
2.C.2.83 |
| SCL |
Sclavo, Inc. |
|
|
2.C.2.83 |
| SOL |
Solvay Pharmaceuticals |
|
CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| SI |
Swiss Serum and Vaccine Inst. |
|
[Inactive--use BPC] |
2.C.2.83 |
| TAL |
Talecris Biotherapeutics |
|
(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006 |
2.C.2.83 |
| USA |
United States Army Medical Research and Material Command |
|
|
2.C.2.83 |
| VXG |
VaxGen |
|
CDC Changes made on: July 14, 2006 |
2.C.2.83 |
| WA |
Wyeth-Ayerst |
|
[Inactive--use WAL] |
2.C.2.83 |
| WAL |
Wyeth-Ayerst |
|
(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) |
2.C.2.83 |
| ZLB |
ZLB Behring |
|
(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb. 28, 2006 |
2.C.2.83 |
| OTH |
Other manufacturer |
|
|
2.C.2.83 |
| UNK |
Unknown manufacturer |
|
|
2.C.2.83 |